Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Hairy Cell × Alemtuzumab × 1 year × Clear all

Sponsor

Conditions

Wilms Tumor 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Pseudomyxoma Peritonei 1 Neuroblastoma 1 Neoplasms, Germ Cell and Embryonal 1 Melanoma 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Kidney Transplantation 1 Digestive System Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Burkitt Lymphoma 1 Adenocarcinoma, Clear Cell 1

Interventions

Rituximab 8 Vemurafenib 4 Cladribine 4 obinutuzumab 3 Specimen Handling 3 Cyclophosphamide 3 Biopsy 3 ibrutinib 2 binimetinib 2 Lenalidomide 2 Diphenhydramine 2 CT-P10 2 Bendamustine Hydrochloride 2 Acetaminophen 2 venetoclax 1 tovorafenib 1 polatuzumab vedotin 1 pembrolizumab 1 immunotoxin HA22 1 fludarabine phosphate 1 fludarabine 1 encorafenib 1 cc-486 1 brexucabtagene autoleucel 1 acalabrutinib 1 Valganciclovir 1 Therapeutics 1 Spinal Puncture 1 Sodium Chloride 1 Prednisone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡